Roughly 1 in 8 American adults take GLP-1 medications for diabetes or weight loss, and use continues to grow, according to a recent KFF Health poll.
The prescription drugs, such as Ozempic or Wegovy, are typically used long-term and may require more complex management than some other treatments.
The American Society of Health-System Pharmacists (ASHP) said pharmacists can play a role in helping patients manage these drugs. Pharmacists working in hospitals, clinics and medical centers often collaborate with physicians and may provide guidance to patients throughout treatment.
“GLP-1s are more complicated than your typical antibiotic or medicines like cholesterol drugs, and they require particular expertise to manage effectively,” said Martin Torres, PharmD, director of pharmacy at the University of California, Irvine.
ASHP outlined several areas where pharmacists may assist patients, including navigating insurance coverage and costs, identifying financial assistance options and helping ensure safe and effective use. The group also said pharmacists may provide guidance on diet and physical activity, as GLP-1 medications reduce appetite and are often used alongside lifestyle changes.
At least half of patients who begin GLP-1 therapy discontinue use within a year, according to ASHP, citing cost, insurance challenges and side effects. Pharmacists may help patients transition off the medications by identifying alternatives, addressing side effects and advising on gradual dose reductions.
This article was constructed with the assistance of artificial intelligence and published by a member of The Washington Times’ AI News Desk team. The contents of this report are based solely on The Washington Times’ original reporting, wire services, and/or other sources cited within the report. For more information, please read our AI policy or contact Steve Fink, Director of Artificial Intelligence, at sfink@washingtontimes.com
The Washington Times AI Ethics Newsroom Committee can be reached at aispotlight@washingtontimes.com.
